• Neurocrine Biosciences named Bret Paulson senior vice president, market access, to lead global market access strategy across its expanding portfolio.
• Paulson joins from Otsuka Pharmaceutical Companies, where he was vice president and head of market access and channel strategy.
• David Bradfute was promoted to senior vice president, global head of intellectual property; he will also serve as managing director of Neurocrine Switzerland in Basel.
• Aaron Vosburgh was promoted to senior vice president, finance and accounting, to oversee enterprise financial strategy and long-range planning.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607231605PR_NEWS_USPR_____LA10558) on July 23, 2026, and is solely responsible for the information contained therein.